Results 211 to 220 of about 7,145,458 (289)

Sengi Exceptionalism

Frontiers in Neuroscience, 2014
Kathleen S Rockland
doaj   +1 more source

Effects of Congenital Adrenal Hyperplasia (CAH) and Biological Sex on Brain Size. [PDF]

Anatomia
Luders E, Gaser C, Spencer D, Thankamony A, Hughes I, Srirangalingam U, Gleeson H, Hines M, Kurth F.   +8 more
europepmc   +1 more source

Clinical and Modifiable Factors Associated With Disability and Relapse in MOGAD: A Multicentre Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Factors associated with relapse course and disability in myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) remain incompletely understood. Objectives To identify clinical and modifiable factors associated with relapse and disability in MOGAD. Methods In this ambispective multicentre cohort study using data from
Yingtao Wang, Shaoxin Tao, Qiujia Wang, Xiaoyu Xu, Hui Yao, Zheng Liu, Dawei Li, Zhandong Qiu, Jinming Han, Jiangwei Xia, Qi Wang, Jun Sun, Kai Shao, Jiao Li, Shishuang Ruan, Yi Zhong, Jun Guo, Shougang Guo, Yue Huang, Guoliang Chai, Tao Jin, Hongyu Zhou, Junwei Hao, Yinan Zhao   +23 more
wiley   +1 more source

Short-term memory, attentional control and brain size in primates. [PDF]

R Soc Open Sci
van Schaik CP, Jacobs I, Burkart JM, Sauciuc GA, Schuppli C, Persson T, Song Z.   +6 more
europepmc   +1 more source

The molecular genetic landscape of human brain size variation

, 2022
Seidlitz J, Mallard TT, Vogel JW, Lee YH, Warrier V, Ball G, Hansson O, Hernandez LM, Mandal AS, Wagstyl K, Lombardo MV, Courchesne E, Glessner JT, Satterthwaite TD, Bethlehem RA, Lifespan Brain Chart Consortium, Tasaki S, Ng B, Gaiteri C, Smoller JW, Ge T, Gandal MJ, Alexander-Bloch AF.   +22 more
europepmc   +1 more source

Differences in brain size [PDF]

Nature, 1992
openaire   +1 more source

Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova, Jan Smeitink, Herma Renkema, Rosabeth White, Frankie Barton, Rachel Lyon, Jane Newman, Aye Moe, Yi Shiau Ng, Grainne Siobhan Gorman   +9 more
wiley   +1 more source

The allometry of brain size in Euarchontoglires: clade-specific patterns and their impact on encephalization quotients. [PDF]

J Mammal
López-Torres S, Bertrand OC, Fostowicz-Frelik Ł, Lang MM, Law CJ, San Martin-Flores G, Schillaci MA, Silcox MT.   +7 more
europepmc   +1 more source

Characterizing Cutaneous α‐Synuclein Deposition and Seeding Activity in Parkinson's Disease Subtypes

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cutaneous phosphorylated α‐synuclein (p‐syn) and α‐synuclein seeding activity are promising biomarkers for Parkinson's disease (PD), but their clinical value remains uncertain due to disease heterogeneity. This study evaluates these two biomarkers in PD patients to inform phenotype‐specific diagnosis and disease severity assessment ...
Yuting Jin, Tianyuan Yang, Minglei Liu, Haiyang Luo, Jing Yuan, Ke Zhang, Xinsheng Han, Jing Yang, Yuming Xu   +8 more
wiley   +1 more source

The reduction in relative brain size in the domesticated dog is not an evolutionary singularity among the canids. [PDF]

Biol Lett
Garamszegi LZ, Kolm N.
europepmc   +1 more source